JP2015525076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015525076A5 JP2015525076A5 JP2015517428A JP2015517428A JP2015525076A5 JP 2015525076 A5 JP2015525076 A5 JP 2015525076A5 JP 2015517428 A JP2015517428 A JP 2015517428A JP 2015517428 A JP2015517428 A JP 2015517428A JP 2015525076 A5 JP2015525076 A5 JP 2015525076A5
- Authority
- JP
- Japan
- Prior art keywords
- btv
- ahsv
- vector
- rna
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013598 vector Substances 0.000 claims 26
- 241000120516 African horse sickness virus Species 0.000 claims 17
- 229920001184 polypeptide Polymers 0.000 claims 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims 16
- 238000000034 method Methods 0.000 claims 9
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 241000134897 Arctic ground squirrel hepatitis B virus Species 0.000 claims 1
- 241000283707 Capra Species 0.000 claims 1
- 241000283073 Equus caballus Species 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659198P | 2012-06-13 | 2012-06-13 | |
| US61/659,198 | 2012-06-13 | ||
| PCT/US2013/045667 WO2013188673A2 (en) | 2012-06-13 | 2013-06-13 | Reassortant btv and ahsv vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015525076A JP2015525076A (ja) | 2015-09-03 |
| JP2015525076A5 true JP2015525076A5 (enExample) | 2016-05-26 |
| JP6347257B2 JP6347257B2 (ja) | 2018-06-27 |
Family
ID=49237584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015517428A Active JP6347257B2 (ja) | 2012-06-13 | 2013-06-13 | 再集合体ｂｔｖおよびａｈｓｖワクチン |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10801039B2 (enExample) |
| EP (1) | EP2861248B1 (enExample) |
| JP (1) | JP6347257B2 (enExample) |
| KR (1) | KR102136437B1 (enExample) |
| CN (2) | CN104582724A (enExample) |
| AU (2) | AU2013274191B2 (enExample) |
| BR (1) | BR112014031133B1 (enExample) |
| CA (1) | CA2876196C (enExample) |
| ES (1) | ES2664069T3 (enExample) |
| IL (1) | IL236148B (enExample) |
| MA (1) | MA37749B1 (enExample) |
| MX (1) | MX364875B (enExample) |
| NZ (1) | NZ703297A (enExample) |
| RU (1) | RU2656187C2 (enExample) |
| TN (1) | TN2014000518A1 (enExample) |
| WO (1) | WO2013188673A2 (enExample) |
| ZA (1) | ZA201409124B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11053509B2 (en) | 2016-04-19 | 2021-07-06 | Csir | Plant-produced chimaeric Orbivirus VLPs |
| WO2017187131A1 (en) * | 2016-04-26 | 2017-11-02 | London School Of Hygiene & Tropical Medicine | Reoviridae vaccine |
| CN110049994B (zh) * | 2016-12-08 | 2023-05-02 | 拜西欧斯（北京）生物技术有限公司 | 一种缀合物及其应用 |
| CN109897092B (zh) * | 2019-04-02 | 2019-11-19 | 深圳海关动植物检验检疫技术中心 | 一种蓝舌病病毒非结构蛋白ns3的可溶制备方法 |
| CN110016466B (zh) * | 2019-05-21 | 2022-09-13 | 云南省畜牧兽医科学院 | 特异性检测蓝舌病病毒的单抗及其杂交瘤细胞株和应用 |
| CN110257560B (zh) * | 2019-07-23 | 2023-06-27 | 深圳海关动植物检验检疫技术中心 | 一种用于蓝舌病病毒8型检测的试剂、检测方法及应用 |
| CN112375848A (zh) * | 2020-12-11 | 2021-02-19 | 云南省畜牧兽医科学院 | 一种蓝舌病病毒血清型鉴定的RT-qPCR检测试剂盒和方法 |
| CN117363588B (zh) * | 2023-02-15 | 2024-08-30 | 中国农业科学院兰州兽医研究所 | 一种表达四半胱氨酸标签重组蓝舌病毒的制备方法及应用 |
| CN120271699B (zh) * | 2025-04-10 | 2026-03-31 | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 一株特异识别蓝舌病毒vp5蛋白的单克隆抗体 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| GB2197321B (en) | 1986-09-12 | 1990-10-03 | Genentech Inc | Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| DE3743138A1 (de) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | Schleifringlose, elektromagnetische ueberlastkupplung |
| EP0575491B1 (en) | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
| JPH11504631A (ja) | 1995-04-25 | 1999-04-27 | バイカル インコーポレイテッド | Ｄｎａ／脂質複合体の単一バイアル製剤 |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
| FR2751229B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
| FR2751228B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
| FR2751225B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
| FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
| FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
| WO1998016247A1 (en) | 1996-10-11 | 1998-04-23 | The Regents Of The University Of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| CA2294793A1 (fr) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede |
| FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
| FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
| US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
| PL1651265T3 (pl) | 2003-07-24 | 2008-10-31 | Merial Ltd | Formulacje szczepionek zawierających emulsję olej w wodzie |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| EP2062594A1 (en) * | 2007-11-21 | 2009-05-27 | Wyeth Farma, S.A. | Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same |
| KR101718497B1 (ko) * | 2007-11-26 | 2017-03-22 | 런던 스쿨 오브 하이진 앤 트로피컬 메디신 | 레오바이러스과 바이러스의 백신용 바이러스 균주를 제조하는 방법 |
-
2013
- 2013-06-13 NZ NZ703297A patent/NZ703297A/en unknown
- 2013-06-13 JP JP2015517428A patent/JP6347257B2/ja active Active
- 2013-06-13 EP EP13766730.9A patent/EP2861248B1/en active Active
- 2013-06-13 AU AU2013274191A patent/AU2013274191B2/en active Active
- 2013-06-13 MA MA37749A patent/MA37749B1/fr unknown
- 2013-06-13 BR BR112014031133-1A patent/BR112014031133B1/pt active IP Right Grant
- 2013-06-13 CA CA2876196A patent/CA2876196C/en active Active
- 2013-06-13 CN CN201380038286.6A patent/CN104582724A/zh active Pending
- 2013-06-13 US US13/917,259 patent/US10801039B2/en active Active
- 2013-06-13 CN CN201910804847.8A patent/CN110628822A/zh active Pending
- 2013-06-13 WO PCT/US2013/045667 patent/WO2013188673A2/en not_active Ceased
- 2013-06-13 MX MX2014015311A patent/MX364875B/es active IP Right Grant
- 2013-06-13 RU RU2015100269A patent/RU2656187C2/ru active
- 2013-06-13 KR KR1020157000827A patent/KR102136437B1/ko active Active
- 2013-06-13 ES ES13766730.9T patent/ES2664069T3/es active Active
-
2014
- 2014-12-09 IL IL236148A patent/IL236148B/en active IP Right Grant
- 2014-12-11 ZA ZA2014/09124A patent/ZA201409124B/en unknown
- 2014-12-12 TN TN2014000518A patent/TN2014000518A1/fr unknown
-
2016
- 2016-10-03 AU AU2016235036A patent/AU2016235036A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015100269A (ru) | Реассортантные btv и ahsv вакцины | |
| ES2662801T3 (es) | Vacunas atenuadas contra Streptoccocus suis y procedimientos de fabricación y uso de las mismas | |
| RU2017113571A (ru) | Рекомбинантные вакцины от fmdv и их применение | |
| CL2019002280A1 (es) | Vectores virales, adenovirales y composiciones a base de una secuencia de ornitina transcarbamilasa humana (hotch) modificada genéticamente y su uso en el tratamiento de deficiencia de la otc. (divisional solicitud 201602235) | |
| JP2017530124A5 (enExample) | ||
| JP2015524422A5 (enExample) | ||
| JP2013502225A5 (enExample) | ||
| PE20141482A1 (es) | Vectores recombinantes de hvt que expresan antigenos de patogenos de aves y sus usos | |
| JP2013517773A5 (enExample) | ||
| JP2015524421A5 (enExample) | ||
| CL2012000447A1 (es) | Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica. | |
| MX2018007860A (es) | Vacunas recombinantes contra el zika. | |
| AR080515A1 (es) | Vacunas recombinantes del virus de la enfermedad del pie y de la boca (fmd1) y sus usos | |
| JP2011530309A5 (enExample) | ||
| NZ598605A (en) | Vaccine against african horse sickness virus | |
| JP2013520977A5 (enExample) | ||
| CO6541529A2 (es) | Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quimericos | |
| JP2014504297A5 (enExample) | ||
| MX338052B (es) | Vectores de parapoxvirus que contienen el antigeno del virus de la rabia. | |
| WO2018102774A8 (en) | Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a | |
| AR082281A1 (es) | Vectores de parapoxvirus | |
| JP2018502080A5 (enExample) | ||
| JP2009522368A5 (enExample) | ||
| JP2014523250A5 (enExample) | ||
| MX388237B (es) | Spv recombinante multivalente |